IMA (Ikena Oncology, Inc.) Gross Sales Margin

Official company branding of ImageneBio Inc (IMA)

The prospects of ImageneBio Inc (IMA) in targeted oncology and the study of tumor metabolism create a positive backdrop, which is reflected in the gross profit margin trend. The value 0.00 captures the current state of this parameter. Efficiency is supported by outsourcing clinical tests to reduce costs, while the stability of the US environment and the humanitarian status of the developments minimize geopolitical risks.

Gross Profitability: ImageneBio Inc (IMA) for 07/29/2025 - 11/19/2026

Financial and market metric breakdowns for ImageneBio (IMA)

- market value and analyst target forecast:
- business market valuation indicators:
Fundamental valuation:IMA - ikenaoncology.com
Signature product of Ikena Oncology

A consistently high profit margin after direct costs confirms the long-term sustainability of the business and its ability to generate added value. By analyzing gross margin variance, investors assess the efficiency of cost coverage, which is critical for ImageneBio Inc (IMA) when scaling clinical trials and seeking strategic partners in the targeted oncology sector.

Main competitors

argenx - Gross Profit Rate|Gross Profitability biontech.de|ABIVAX (ABVX) - Return on Sales by Gross Profit|Gross Margin ADMA|Gross Profit Ratio PTGX|Gross Profitability Immunovant Corp IMVT|Gross Margin Kiniksa Pharmaceuticals, Ltd. KNSA|GRFS - Gross Profitability|Return on Sales by Gross Profit Adaptive Biotechnologies ADPT|CLDX (Celldex Therapeutics, Inc.) - Return on Gross Profit|Aurinia Pharmaceuticals Inc. (AUPH) - Gross Margin|Return on Gross Profit BCRX|Gross Profit Margin Vera Therapeutics Inc VERA|Return on Gross Profit DNTH (Dianthus Pharma)|Return on Sales by Gross Profit Pharvaris N.V.|AbCellera Biologics Inc - Return on Gross Profit|Tourmaline Bio (TRML) - Gross Profit Margin|PGEN - Gross Profitability|Gross Profit Rate PHAR (Pharming Group NV)|NKTR: Gross Margin|Upstream Bio Corp - Gross Profit Rate|Gross Profitability Zenas Biopharma Inc|Immunome, Inc. (IMNM) - Return on Sales by Gross Profit|Gross Margin GOSS|Return on Gross Profit KalVista Pharmaceuticals, Inc. KALV|Gross Profitability Septerna SEPN|Pieris Pharmaceuticals (PVLA) - Gross Profit Margin|SVRA - Gross Profitability|Rigel Pharmaceuticals - Gross Profit Ratio|AnaptysBio Corp (ANAB) - Gross Profitability|ATXS - Return on Sales by Gross Profit|Gross Profitability enGene Holdings Inc.|RAPT: Gross Profit Rate|Gross Margin JBIO|Return on Gross Profit aclaristx.com ACRS|Gross Profitability Kyverna Therapeutics Inc. KYTX|Tiziana Life Sciences Ltd. (TLSA) - Gross Profit Margin|Cabaletta Bio, Inc - Gross Margin|Gross Profit Margin Ventyx Biosciences|THTX (theratech.com) - Return on Gross Profit|Return on Gross Profit Avalo Therapeutics, Inc|ELDN (Eledon Pharmaceuticals, Inc) - Gross Margin|Gross Profit Margin Agenus Inc. AGEN|Return on Gross Profit CLYM (Climb Bio, Inc.)|ZURA (Zura Bio Ltd) - Gross Profit Rate|Gross Profitability atyrpharma.com ATYR|Gross Margin Adagene Corp ADAG|STTK - Gross Profitability|EQ (equilliumbio.com) - Gross Return on Sales|CNTB: Gross Margin|Immunic Inc (IMUX) - Gross Margin|ATRA (Atara Biotherapeutics Inc) - Gross Margin|Gross Return on Sales IFRX (InflaRx N.V.)|x4pharma.com (XFOR) - Gross Profit Rate|Adicet Bio, Inc. - Gross Return on Sales|Celularity Inc - Return on Gross Profit|Gross Margin INmune Bio Corporation INMB|Barinthus Biotherapeutics - Gross Margin|Kezar Life Sciences, Inc. (KZR) - Return on Gross Profit|SAB Biotherapeutics Inc. (SABS) - Gross Profitability|Return on Gross Profit Akari Therapeutics plc|Gross Profitability enlivex.com|q32bio.com (QTTB) - Return on Sales by Gross Profit|Gross Margin GOVX|Edesa Biotech, Inc. - Gross Return on Sales|iBio Inc - Return on Gross Profit|Gross Margin Carisma Therapeutics CARM|XTLB - Gross Profitability|BOLT (boltbio.com) - Gross Return on Sales|HCWB: Gross Margin|Aptevo (APVO) - Gross Margin|Gross Profitability AIM ImmunoTech|Return on Gross Profit Aditxt (ADTX)|Return on Gross Profit GRI (GRI Bio Corporation)|XORTX - Gross Return on Sales|Gross Margin HIND (Vyome Holdings Inc.)|Gross Profit Rate REVB|Indaptus - Gross Margin|SCNI (Scinai Immunotherapeutics Ltd.) - Gross Return on Sales|CALI: Gross Margin|Affimed NV - Gross Profit Rate|Gross Profitability Allakos Inc.|Gross Margin HOOKIPA Pharma|Gross Profitability IGM Biosciences, Inc. (IGMS)|ITOS - Gross Profit Margin|Gross Margin OCEA (Ocean Bio)|Gross Profit Rate TCBP|THRD - Gross Profitability